Furthermore, in a large population-based study carried out in Denmark, statin use was associated with a reduced risk of breast cancer recurrence in postmenopausal women receiving adjuvant aromatase inhibitors (following multivariate analysis, HR 0.72; 95% CI 0.50–1.04) [36]. This evidence concerns the gene CYP19A1 and breast cancer.